Agreement signedAgreed 3 Apr 2024

Oruka Therapeutics, Inc. /
ARCA

Oruka Therapeutics and ARCA biopharma merger proceeds under agreement

Buy side: Oruka Therapeutics, Inc.
Buy sideOruka Therapeutics, Inc.
Target: ARCA
TargetARCA
Source · 3 Apr 2024Source-verified
Buy side: Oruka Therapeutics, Inc.
Buy sideOruka Therapeutics, Inc.
Target: ARCA
TargetARCA
01 / BuyerOruka Therapeutics, Inc.
02 / TargetARCA
Source-verified
01

What happened

Oruka Therapeutics, Inc. and ARCA biopharma, Inc. are parties to a merger agreement dated April 3, 2024. ARCA announced an update to its special cash dividend, which will be $1.613 per share and payable Aug. 28, 2024.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Oruka Therapeutics and ARCA biopharma merger proceeds under agreement

This document is the source for the companies, stage, figure and people on this page.

Source-verified
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Announced

    The source this page is built from.

    Source-verified
  2. Published by the source

    The source this page is built from.

    Source-verified
  3. Also stated

    The source this page is built from.

    Source-verified

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request an inviteAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.